Author:
Giadone Richard M.,Ghosh Sabrina,Murphy George J.
Reference65 articles.
1. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
2. Recent advances in the treatment of familial amyloid polyneuropathy;Adams;Ther. Adv. Neurol. Disord.,2013
3. Transthyretin-related familial amyloidotic polyneuropathy;Ando;Arch. Neurol.,2005
4. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: a phase III, open-label study;Ando;J. Neurol. Sci.,2016
5. The $2.6 billion pill—methodologic and policy considerations;Avorn;N. Engl. J. Med.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献